Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo

94Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

Recently it has been demonstrated that catecholamines are produced and used by macrophages and mediate immune response. The aim of this study is to verify whether endothelial cells (ECs), which are of myeloid origin, can produce catecholamines. We demonstrated that genes coding for tyrosine hydroxylase, Dopa decarboxylase, dopamine β hydroxylase (DβH), and phenylethanolamine- iV-methyl transferase, enzymes involved in the synthesis of catecholamines, are all expressed in basal conditions in bovine aorta ECs, and their expression is enhanced in response to hypoxia. Moreover, hypoxia enhances catecholamine release. To evaluate the signal transduction pathway that regulates catecholamine synthesis in ECs, we overexpressed in bovine aorta ECs either protein kinase A (PKA) or the transcription factor cAMP response element binding, because PKA/cAMP response element binding activation induces tyrosine hydroxylase transcription and activity in response to stress. Both cAMP response element binding and PKA overexpression enhance DβH and phenylethanolamine-iV-methyl transferase gene expression and catecholamine release, whereas H89, inhibitor of PKA, exerts the opposite effect, evidencing the role of PKA/cAMP response element binding transduction pathway in the regulation of catecholamine release in bovine aorta ECs. We then evaluated by immunohistochemistry the expression of tyrosine hydroxylase, Dopa decarboxylase, DβH, and phenylethanolamine-iV-methyl transferase in femoral arteries from hindlimbs of C57Bl/6 mice 3 days after removal of the common femoral artery to induce chronic ischemia. Ischemia evokes tyrosine hydroxylase, Dopa decarboxylase, DβH, and phenylethanolamine-iV-methyl transferase expression in the endothelium. Finally, the pharmacological inhibition of catecholamine release by fusaric acid, an inhibitor of DβH, reduces the ability of ECs to form network-like structures on Matrigel matrix. In conclusion, our study demonstrates for the first time that ECs are able to synthesize and release catecholamines in response to ischemia. © 2012 American Heart Association, Inc.

References Powered by Scopus

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

10695Citations
N/AReaders
Get full text

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

9806Citations
N/AReaders
Get full text

Molecular mechanisms and clinical applications of angiogenesis

4405Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Hypertension, thrombosis, kidney failure, and diabetes: Is covid-19 an endothelial disease? a comprehensive evaluation of clinical and basic evidence

399Citations
N/AReaders
Get full text

Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells

173Citations
N/AReaders
Get full text

Arginine and endothelial function

162Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sorriento, D., Santulli, G., Del Giudice, C., Anastasio, A., Trimarco, B., & Iaccarino, G. (2012). Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension, 60(1), 129–136. https://doi.org/10.1161/HYPERTENSIONAHA.111.189605

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 26

62%

Professor / Associate Prof. 8

19%

Researcher 7

17%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 12

32%

Medicine and Dentistry 11

30%

Biochemistry, Genetics and Molecular Bi... 9

24%

Pharmacology, Toxicology and Pharmaceut... 5

14%

Save time finding and organizing research with Mendeley

Sign up for free